Brahim K Bookhart Selected Research

Overweight

1/2023	Weight and BMI Changes Following Initiation of Emtricitabine/Tenofovir Alafenamide Co-Formulated with Darunavir or Co-Administered with Dolutegravir in Overweight or Obese, ART-Naïve People Living with HIV-1.
12/2012	Use of warfarin therapy among residents who developed venous thromboembolism in the nursing home.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Brahim K Bookhart Research Topics

Disease

9	Venous Thromboembolism 01/2023 - 01/2011
6	Hemorrhage 01/2023 - 01/2011
6	Neoplasms (Cancer) 10/2014 - 01/2006
5	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 01/2014
4	Atrial Fibrillation 01/2023 - 01/2015
4	Weight Gain 01/2023 - 10/2022
4	Chronic Renal Insufficiency 05/2008 - 01/2006
3	Pulmonary Embolism 03/2015 - 01/2014
3	Anemia 05/2009 - 02/2008
2	Stroke (Strokes) 01/2023 - 01/2023
2	Overweight 01/2023 - 12/2012
1	Thrombosis (Thrombus) 01/2023
1	Embolism (Embolus) 01/2023
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2023
1	Ischemic Stroke 01/2023
1	Heart Failure 01/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023
1	Transient Ischemic Attack 01/2023
1	Body Weight (Weight, Body) 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Lipodystrophy 01/2023
1	Obstructive Sleep Apnea 01/2023
1	Myocardial Infarction 01/2023
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Pain (Aches) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 12/2012
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 12/2012
1	Dementia (Dementias) 12/2012
1	Glaucoma 08/2002

Drug/Important Bio-Agent (IBA)

8	Warfarin (Coumadin)FDA LinkGeneric 01/2023 - 10/2011
6	RivaroxabanIBA 01/2023 - 01/2014
6	AnticoagulantsIBA 01/2019 - 12/2012
3	IntegrasesIBA 01/2023 - 01/2023
3	Epoetin Alfa (Epogen)FDA Link 05/2008 - 01/2006
2	Vitamin K FDA Link 01/2019 - 01/2014
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2016 - 01/2014
2	Hemoglobins (Hemoglobin)IBA 01/2011 - 05/2008
2	HematinicsIBA 05/2009 - 03/2009
2	Darbepoetin alfa (Aranesp)FDA Link 08/2007 - 01/2006
1	emtricitabine tenofovir alafenamideIBA 01/2023
1	Darunavir (Prezista)FDA Link 01/2023
1	tenofovir alafenamideIBA 01/2023
1	CobicistatIBA 01/2023
1	LipidsIBA 01/2023
1	Emtricitabine (Emtriva)FDA Link 01/2023
1	RacivirIBA 01/2023
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2023
1	dolutegravirIBA 01/2023
1	apixabanIBA 11/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 01/2019
1	SodiumIBA 01/2019
1	SymportersIBA 01/2019
1	AcidsIBA 01/2016
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2014
1	Antipsychotic Agents (Antipsychotics)IBA 12/2012

Therapy/Procedure

7	Therapeutics 10/2022 - 08/2002
4	Drug Therapy (Chemotherapy) 05/2009 - 01/2006
3	Art Therapy 01/2023 - 10/2022
2	Knee Replacement Arthroplasty (Total Knee Replacement) 10/2011 - 01/2011
1	Length of Stay 01/2019
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2016
1	Duration of Therapy 10/2014
1	Home Nursing (Nursing, Home) 12/2012
1	Long-Term Care 12/2012
1	Arthroplasty 10/2011
1	Organ Transplantation 05/2009